These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38550817)

  • 21. Uncommon Presentation of a Common Histiocytic Tumor: A Rare Entity.
    Kar C; Das K; Barua JK
    Indian J Dermatol; 2015; 60(3):301-4. PubMed ID: 26120163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eruptive xanthogranuloma in a healthy adult male.
    Ederle A; Kim KH; Gardner JM
    J Cutan Pathol; 2017 Apr; 44(4):385-387. PubMed ID: 28000234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benign cephalic histiocytosis progressing into juvenile xanthogranuloma: a non-Langerhans cell histiocytosis transforming under the influence of a virus?
    Rodriguez-Jurado R; Duran-McKinster C; Ruiz-Maldonado R
    Am J Dermatopathol; 2000 Feb; 22(1):70-4. PubMed ID: 10698221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant adult onset xanthogranuloma and IgG4-related orbital disease: a rare occurrence.
    Andron AA; Nair AG; Della Rocca D; Della Rocca RC; Reddy HS
    Orbit; 2022 Feb; 41(1):108-111. PubMed ID: 32847452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIMP-1 Mediates Inflammatory and Immune Response to IL-6 in Adult Orbital Xanthogranulomatous Disease.
    Ding X; Cao Y; Xing Y; Ge S; Lin M; Li J
    Ocul Immunol Inflamm; 2020; 28(2):288-297. PubMed ID: 30973282
    [No Abstract]   [Full Text] [Related]  

  • 26. Bilateral adult epibulbar xanthogranulomas suspicious for Erdheim-Chester disease.
    Aggarwal S; Jakobiec FA; Hamrah P
    Cornea; 2014 Oct; 33(10):1113-7. PubMed ID: 25014153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adult onset xanthogranuloma in a 73-year-old woman].
    von Sperling ML; Høimyr H
    Ugeskr Laeger; 2011 May; 173(19):1366-7. PubMed ID: 21561577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment with cladribine of Erdheim-Chester disease with orbital and central nervous system involvement developing after treatment of Langerhans cell histiocytosis.
    Perić P; Antić B; Knezević-Usaj S; Radić-Tasić O; Radovinović-Tasić S; Vasić-Vilić J; Sekulović L; Tarabar O; Tukić L; Jovandić S; Magić Z
    Vojnosanit Pregl; 2016 Jan; 73(1):83-7. PubMed ID: 26964390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult Orbital and Adnexal Xanthogranulomatous Disease.
    Davies MJ; Whitehead K; Quagliotto G; Wood D; Patheja RS; Sullivan TJ
    Asia Pac J Ophthalmol (Phila); 2017; 6(5):435-443. PubMed ID: 28829109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous adult xanthogranuloma with a small portion of BRAF
    Ishikawa M; Endo Y; Uehara A; Suto M; Yasuda M; Motegi SI; Ishikawa O
    J Dermatol; 2019 Feb; 46(2):161-165. PubMed ID: 30536719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orbital xanthogranuloma: clinical and morphologic features in eight patients.
    Karcioglu ZA; Sharara N; Boles TL; Nasr AM
    Ophthalmic Plast Reconstr Surg; 2003 Sep; 19(5):372-81. PubMed ID: 14506422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solitary giant xanthogranuloma and benign cephalic histiocytosis--variants of juvenile xanthogranuloma.
    Zelger BG; Zelger B; Steiner H; Mikuz G
    Br J Dermatol; 1995 Oct; 133(4):598-604. PubMed ID: 7577591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological study of ophthalmic cutaneous and mucocutaneous non-langerhans cell histiocytic lesions.
    Alkatan HM; Fatani DR; Maktabi AMY; Alzahem TA
    BMC Ophthalmol; 2024 Mar; 24(1):124. PubMed ID: 38504269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult orbital xanthogranulomatous disease: review of the literature.
    Guo J; Wang J
    Arch Pathol Lab Med; 2009 Dec; 133(12):1994-7. PubMed ID: 19961259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orbital necrobiotic xanthogranuloma with necrotizing scleritis and absent cutaneous manifestations.
    Herrera J; Reid G; McCluskey P; Tumuluri K
    Orbit; 2024 Aug; ():1-5. PubMed ID: 39110073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytological diagnosis of juvenile xanthogranuloma: A rare histiocytic disorder.
    Chauhan S; Diwaker P; Singh A; Gogoi P; Arora VK
    Diagn Cytopathol; 2020 Jan; 48(1):66-70. PubMed ID: 31432610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solitary and generalized variants of spindle cell xanthogranuloma (progressive nodular histiocytosis).
    Zelger BW; Staudacher C; Orchard G; Wilson-Jones E; Burgdorf WH
    Histopathology; 1995 Jul; 27(1):11-9. PubMed ID: 7557901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile and adult xanthogranuloma: A 30-year single-center experience and review of the disorder and its relationship to other histiocytoses.
    Salari B; Dehner LP
    Ann Diagn Pathol; 2022 Jun; 58():151940. PubMed ID: 35378409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological evidence of MAPK pathway activation across subtypes of adult orbital xanthogranulomatous disease irrespective of the detection of oncogenic mutations.
    Detiger SE; Paridaens D; Kemps PG; van Halteren AGS; van Hagen PM; van Laar JAM; Verdijk RM
    Clin Immunol; 2024 Aug; 265():110299. PubMed ID: 38936524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
    Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R
    Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.